DK1883665T3 - Polylactidsammensætninger og anvendelser deraf - Google Patents

Polylactidsammensætninger og anvendelser deraf

Info

Publication number
DK1883665T3
DK1883665T3 DK06809004.2T DK06809004T DK1883665T3 DK 1883665 T3 DK1883665 T3 DK 1883665T3 DK 06809004 T DK06809004 T DK 06809004T DK 1883665 T3 DK1883665 T3 DK 1883665T3
Authority
DK
Denmark
Prior art keywords
applications
polylactide compositions
polylactide
compositions
Prior art date
Application number
DK06809004.2T
Other languages
Danish (da)
English (en)
Inventor
Michael Moller
Thomas Trimaille
Robert Gurny
Original Assignee
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Geneve filed Critical Univ Geneve
Application granted granted Critical
Publication of DK1883665T3 publication Critical patent/DK1883665T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78—Preparation processes
    • C08G63/82—Preparation processes characterised by the catalyst used
    • C08G63/823—Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DK06809004.2T 2005-04-22 2006-04-21 Polylactidsammensætninger og anvendelser deraf DK1883665T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67410305P 2005-04-22 2005-04-22
US75014105P 2005-12-14 2005-12-14
PCT/IB2006/002849 WO2007012979A2 (en) 2005-04-22 2006-04-21 Polylactide compositions and uses thereof

Publications (1)

Publication Number Publication Date
DK1883665T3 true DK1883665T3 (da) 2017-11-13

Family

ID=37603048

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06809004.2T DK1883665T3 (da) 2005-04-22 2006-04-21 Polylactidsammensætninger og anvendelser deraf

Country Status (9)

Country Link
US (5) US8466133B2 (enExample)
EP (2) EP1883665B1 (enExample)
JP (5) JP5749881B2 (enExample)
CA (1) CA2605652C (enExample)
DK (1) DK1883665T3 (enExample)
ES (1) ES2646141T3 (enExample)
PL (1) PL1883665T3 (enExample)
PT (1) PT1883665T (enExample)
WO (1) WO2007012979A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1883665T (pt) * 2005-04-22 2017-11-14 Univ Geneve Composições polilactídeo e usos das mesmas
WO2008121702A2 (en) * 2007-03-28 2008-10-09 Boston Scientific Scimed, Inc. Medical devices having bioerodable layers for the release of therapeutic agents
WO2009025719A1 (en) * 2007-08-03 2009-02-26 University Of Massachusetts Medical School Polymer compositions for biomedical and material applications
US8697098B2 (en) * 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
CN101665566B (zh) * 2008-09-01 2012-01-04 南京工业大学 一种利用双螺杆挤出机制备聚乳酸及其制品的方法
FR2942800B1 (fr) * 2009-03-06 2012-04-20 Minasolve Procede de polymerisation par voie catalytique de 1,4-dioxanes-2,5 diones et les polymeres correspondants
WO2011082479A1 (en) * 2010-01-08 2011-07-14 University Of Prince Edward Island Star polymers having controlled tacticity and methods of making same
ES2581837T3 (es) 2010-07-26 2016-09-07 Université De Genève Composiciones que comprenden polímeros preparados a partir de ácidos 2-hidroxi alquil
KR101952599B1 (ko) 2011-02-25 2019-05-22 사우스다코타주립대학 고분자 컨쥬게이트화된 단백질 마이셀
WO2013083605A1 (en) 2011-12-05 2013-06-13 Ferring Bv Triptorelin pharmaceutical composition
ES2604837T3 (es) 2012-02-02 2017-03-09 Esbatech - A Novartis Company Llc Formulación de liberación sostenida que contiene anticuerpos para administración ocular
AR090736A1 (es) * 2012-04-20 2014-12-03 Sucampo Ag Conjugado de compuesto triciclo-polimero
AR092821A1 (es) * 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
EP2941422B1 (en) * 2013-02-08 2017-04-05 Total Research & Technology Feluy SA Process for preparing cyclic esters and cyclic amides
US8975344B2 (en) * 2013-07-10 2015-03-10 Xerox Corporation Polyester/polycarbonate block copolymers via one-pot, neat ring opening polymerization
US9080012B2 (en) * 2013-07-10 2015-07-14 Xerox Corporation One-pot, neat ring opening polymerization to prepare resin
DE102013018193A1 (de) 2013-10-30 2015-05-13 Martin-Luther-Universität Halle-Wittenberg, Körperschaft des öffentlichen Rechts Injizierbare Depotformulierungen zur kontrollierten Wirkstofffreisetzung
CA2940955C (en) * 2014-02-26 2022-03-15 University Of Massachusetts Medical School Amphiphilic degradable polymers for immobilization and sustained delivery of biomolecules
DE102014005782A1 (de) 2014-04-23 2015-10-29 Martin-Luther-Universität Halle-Wittenberg lnjizierbare und implantierbare Trägersysteme auf Basis von modifizierten Poly(dikarbonsäure-multiol estern) zur kontrollierten Wirkstofffreisetzung
CN106659731A (zh) * 2014-05-30 2017-05-10 夏尔人类遗传性治疗公司 用于递送核酸的可生物降解脂质
US10822491B2 (en) * 2014-11-17 2020-11-03 Roquette Freres Composition of polyester and thermoplastic starch, having improved mechanical properties
WO2016100520A1 (en) * 2014-12-16 2016-06-23 Boston Scientific Scimed, Inc. Bioerodible polymer compositions
US9260550B1 (en) 2015-01-27 2016-02-16 International Business Machines Corporation Lactide-based acrylate polymers
JP6148701B2 (ja) * 2015-07-31 2017-06-14 ユニベルシテ ドゥ ジュネーブ ２−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
US10570252B2 (en) 2017-03-08 2020-02-25 International Business Machines Corporation Flame retardant lactide monomors for polylactide synthesis
US10202489B2 (en) 2017-03-08 2019-02-12 International Business Machines Corporation Lactide copolymers and ring-opened lactide copolymers
US10072121B1 (en) 2017-03-08 2018-09-11 International Business Machines Corporation Bottlebrush polymers derived from poly(methylidenelactide)
US10035877B1 (en) 2017-03-08 2018-07-31 International Business Machines Corporation Matrix-bondable lactide monomors for polylactide synthesis
EP3743041A1 (en) 2018-01-26 2020-12-02 Apidel SA New spironolactone formulations and their use
CA2994005A1 (fr) * 2018-02-05 2019-08-05 Hydro-Quebec Copolymeres d'unites ester et ether, leurs procedes de fabrication et leurs utilisations
EP3656378A1 (en) * 2018-11-26 2020-05-27 ValMeyer Sàrl New composition of amide and ester local anesthetics and uses thereof
US11407855B2 (en) 2019-08-23 2022-08-09 The Board Of Trustees Of The University Of Illinois Ring opening polymerization in an aqueous dispersion
CN116217900A (zh) * 2021-12-02 2023-06-06 惠生工程（中国）有限公司 一种乙交酯、丙交酯开环共聚合制备pgla的装置及工艺
WO2024064758A2 (en) * 2022-09-21 2024-03-28 Hercules Llc Coating composition comprising a bioresorbable copolymer and an anti-microbial agent

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
US5725871A (en) 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
CA2110899C (en) 1991-06-21 2006-08-08 Jacob G. Michael Orally administrable therapeutic proteins and method of making
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
CA2087125A1 (en) * 1992-01-23 1993-07-24 Mridula Nair Chemically fixed micelles
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5686630A (en) * 1993-09-29 1997-11-11 Chronopol, Inc. Purifying cyclic esters by aqueous solvent extraction
DE69312487T2 (de) 1992-05-18 1997-11-27 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
KR970002523B1 (en) * 1993-04-24 1997-03-05 Korea Inst Sci & Tech Biodegradable polylactic acid having improved properties and method for manufacturing the same
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6007845A (en) * 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5580579A (en) 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
WO2001042333A2 (en) * 1999-12-13 2001-06-14 Michigan State University Process for the preparation of polymers of dimeric cyclic esters
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
KR100484371B1 (ko) 2001-10-25 2005-04-20 가부시키가이샤 아텍스 히터선부착 시트체의 제조방법
DE60333566D1 (de) * 2002-08-13 2010-09-09 Medtronic Inc Medizinische vorrichtung mit verbesserter haftung zwischen einem polymeren berzug und einem substrat
DE60325240D1 (de) * 2002-09-26 2009-01-22 Angiotech Int Ag Perivaskuläre hüllen
US7533176B2 (en) 2004-07-14 2009-05-12 International Business Machines Corporation Method for supporting connection establishment in an offload of network protocol processing
PT1883665T (pt) * 2005-04-22 2017-11-14 Univ Geneve Composições polilactídeo e usos das mesmas

Also Published As

Publication number Publication date
US20160367680A1 (en) 2016-12-22
JP6491614B2 (ja) 2019-03-27
US20150073060A1 (en) 2015-03-12
US8741877B2 (en) 2014-06-03
JP2016128506A (ja) 2016-07-14
US20090281068A1 (en) 2009-11-12
EP1883665A2 (en) 2008-02-06
EP3339348B1 (en) 2019-12-04
JP2014065722A (ja) 2014-04-17
WO2007012979A2 (en) 2007-02-01
US20130331464A1 (en) 2013-12-12
US20180271984A1 (en) 2018-09-27
EP3339348A1 (en) 2018-06-27
JP5749881B2 (ja) 2015-07-15
EP1883665B1 (en) 2017-10-11
PT1883665T (pt) 2017-11-14
ES2646141T3 (es) 2017-12-12
CA2605652C (en) 2016-05-24
US10314913B2 (en) 2019-06-11
JP2017222712A (ja) 2017-12-21
WO2007012979A3 (en) 2007-05-03
PL1883665T3 (pl) 2018-05-30
JP2015038121A (ja) 2015-02-26
JP6346540B2 (ja) 2018-06-20
US9925267B2 (en) 2018-03-27
US9375482B2 (en) 2016-06-28
CA2605652A1 (en) 2007-02-01
JP2008538589A (ja) 2008-10-30
JP6559198B2 (ja) 2019-08-14
US8466133B2 (en) 2013-06-18

Similar Documents

Publication Publication Date Title
DK1883665T3 (da) Polylactidsammensætninger og anvendelser deraf
DK1751087T3 (da) Levodopa-derivater og sammensætninger og anvendelser deraf
DK1866339T3 (da) GTR-bindende molekyler og anvendelser heraf
EP1937824A4 (en) TRNA COMPOSITIONS AND ITS USES
EP1913800A4 (en) NANOELECTROMECHANICAL AND MICROELECTROMECHANICAL SENSORS AND ANALYZERS
EP1781098A4 (en) ANTIMICROBIAL DEVICES AND COMPOSITIONS THEREFOR
DK3090748T3 (da) Sammensætninger, der omfatter nukleotid- og oligonukleotid-prodrugs
DK1959948T3 (da) Levodopa prodrug-mesylat, sammensætninger deraf og anvendelser deraf
DK2059535T3 (da) Prlr-specifikt antistof og anvendelser deraf
DK2063907T3 (da) Fremgangsmåder og sammensætninger baseret på difteritoksin-interleukin-3-konjugater
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
BRPI0511900A (pt) composições farmacêuticas
DK2012773T3 (da) Lægemidler og anvendelser deraf
LTPA2019017I1 (lt) Oftalmologinės kompozicijos ir jų panaudojimas
DE602006020159D1 (de) Härtbare silikonzusammensetzung
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
EP1889304A4 (en) THERMOELECTRIC COMPOSITIONS AND METHOD
DK1858488T4 (da) Tigecyclinsammensætninger og fremgangsmåder til fremstilling deraf
NO20055686D0 (no) Sammensetning
DK3309233T4 (da) Sammensætninger omfattende hfc-1234yf og hfc-152a
DK2176284T3 (da) Lantibiotika og anvendelser deraf
DK1976548T3 (da) VIP-fragmenter og sammensætninger deraf
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
DE602006016137D1 (de) Harzzusammensetzungen und harzformkörper